Compass Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$988K Buy
2,345
+500
+27% +$199K 0.06% 65
2026
Q2
$668K Sell
1,845
-500
-21% -$171K 0.04% 64
2026
Q1
$825K Hold
2,345
– – 0.05% 57
2025
Q4
$768K Hold
2,345
– – 0.04% 61
2025
Q3
$662K Hold
2,345
– – 0.04% 62
2025
Q2
$655K Buy
+2,345
New +$664K 0.04% 55

Other funds holding AMGN

Compass Capital Management's AMGN Position: Q3 2026 in Review

Compass Capital Management increased its Amgen (AMGN) stake by 27% in Q3 2026, buying an estimated $199K and bringing the position to 2,345 shares worth $988K. The position accounts for 0.06% of the portfolio, ranked #65.

Compass Capital Management first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Compass Capital Management held 2,345 shares of Amgen worth $988K as of Q3 2026.
  • Compass Capital Management bought 500 Amgen shares in Q3 2026, an estimated $199K.
  • Amgen made up 0.06% of Compass Capital Management's portfolio in Q3 2026, its #65 holding.
  • Compass Capital Management first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Compass Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.